Caption Management, LLC Gilead Sciences, Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.35 Million - $1.53 Million	18,400 New	18,400 $1.49 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $2.36 Million - $2.69 Million	-39,600 Reduced 25.8%	113,900 $7.03 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $7.5 Million - $8.45 Million	130,000 Added 553.19%	153,500 $9.49 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $4.22 Million - $4.79 Million	-65,000 Reduced 73.45%	23,500 $1.71 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $2.37 Million - $2.56 Million	35,000 Added 65.42%	88,500 $6.18 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $222,145 - $242,724	3,500 Added 7.0%	53,500 $3.68 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $3.13 Million - $3.45 Million	50,000 New	50,000 $3.17 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.